Summary

Overview
Global Actigraphy Sensors and PSG Devices Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031
Actigraphy sensors are portable and non-invasive devices used to track the sleep-wake patterns of individuals. They are more commonly used in home and non-clinical settings. Actigraphy plays a vital role in diagnosing various sleep disorders like insomnia, circadian rhythm sleep-wake disorders, sleep apnea, and insufficient sleep syndrome.
PSG devices are used in clinical settings for the diagnosis and treatment of sleep disorders. They provide more comprehensive data on sleep stages, breathing patterns, and other physiological parameters.

Market Dynamics: Drivers & Restraints
Rise in the prevalence of sleep disorders
The rising prevalence of sleep disorders, such as insomnia, sleep apnea, and restless legs syndrome, is a major driver of the actigraphy sensors and PSG devices market. As awareness about these conditions grows and their impact on overall health becomes more evident, there is a greater demand for diagnostic tools to monitor and manage sleep patterns effectively.
For instance, according to the American Psychiatric Association, about one-third of adults report some insomnia symptoms, 10 to 15% report problems with functioning during the daytime and 4 to 22% have symptoms severe enough to meet the criteria for insomnia disorder. An estimated 40 to 50% of individuals with insomnia also have another mental disorder.

Challenges associated with the devices
The most important challenges are the development of nonintrusive hardware implementation, smart signal processing, data analysis and interpretation, communication standards interoperability, electronic component efficiency, energy self-sufficiency, and long-term monitoring.

For more details on this report ? Request for Sample
Segment Analysis
The global actigraphy sensors and PSG devices market is segmented based on product type, application, configuration end-user and region.
The actigraphy sensors from the product type segment accounted for approximately 51.3% of the Actigraphy sensors and PSG devices market share
The actigraphy sensors from the product type segment accounted for approximately 51.3%. Actigraphy is indicated for determining the sleep-wake patterns of patients with insomnia and circadian rhythm disorders and for determining the response to therapy in patients with circadian rhythm disorders. Studies of actigraphy have usually compared the results with those of PSG or sleep logs.
Actigraphy sensors are expected to have a high market share due to novel product launches, increased COVID-19 infections, awareness, and relaxation of restrictions in industrialized countries. Demand for these devices is expected to grow due to increased awareness of sleep deprivation treatments, product availability, and advanced public sector healthcare facilities and organizations.
For instance, in November 2023, ActiGraph, a leader in wearable digital health technology and digital health sciences for clinical drug development and academic research, introduced its next-generation multisensor wearable, the ActiGraph LEAP.
Moreover, in April 2023, Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, announced the launch of Empatica Actigraphy, a powerful new addition to the company's FDA-cleared Empatica Health Monitoring Platform, offering a new set of digital biomarkers for monitoring sleep and physical activity along with the capability to collect data continuously for up to 14 days on a single charge.
Geographical Analysis
North America is estimated to hold about 42.4% of the total market share throughout the forecast period
North America is estimated to hold about 42.4% of the total market share throughout the forecast period owing to factors like novel product launches by companies, FDA approvals, the rising geriatric population, the high prevalence of chronic sleep disorders, the efficiency and affordability of the industry with the technological breakthroughs, as well as the presence of established research institutions.
For instance, in March 2024, Beacon Biosignals announced that it had received FDA 510(k) clearance for SleepStageML, an advanced machine learning software that automatically stages sleep from electroencephalogram (EEG) signals of clinical polysomnography (PSG) recordings to aid in the diagnosis and evaluation of sleep and sleep-related disorders.
Covid 19 Impact Analysis
The COVID-19 pandemic has significantly disrupted the actigraphy sensors and PSG devices market, leading to increased demand for products like telehealth, remote testing, and data monitoring. This has led to increased interest in remote diagnostic and data monitoring technology, particularly in disposable home sleep apnea testing devices. This has accelerated the use of wearables and AI/ML/DL integrations, enhancing the quality of sleep care.
Market Segmentation
By Product Type
- Actigraphy Sensors
- Wrist and Handband Actigraphy Devices
- Wearable Actigraphy Devices
- Polysomnography Devices
- Fixed Polysomnography Devices
- Portable Polysomnography Devices
By Application
- Sleep Monitoring
- Fitness Monitoring
- Disease Monitoring
- Clinical Research
- Others
By Configuration
- Wristband
- Neck and head bands
- Sensor Caps
- Others
By End-User
- Hospitals and Clinics
- Homecare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Competitive Landscape
The major global players in the market include Koninklijke Philips N.V., Neurocare Group, Cadwell Laboratories Inc., SOMNOmedics GmbH, ActiGraph LLC, Advanced Brain Monitoring Inc., Nox Medical, BMC, Cidelec, Compumedics among others.
Key Developments
- In April 2022, Onera Health received the US Food and Drug Administration clearance for their non-invasive patch-based clinical-grade compact medical device for polysomnography, Onera STSI, designed to diagnose sleep disorders in patients in hospitals, sleep laboratories, or home settings.
- In March 2020, Nox Medical officially launched its innovative polysomnographic system, the Nox A1, in the U.S. and Canada. The Nox A1 is a powerful, ambulatory PSG device that combines thoughtful design with clinical accuracy, allowing sleep labs to maximize their investment with multiple functions in one single device.
Why Purchase the Report?
- To visualize the global actigraphy sensors and PSG devices market segmentation based on product type, application, configuration, end user and region as well as understand key commercial assets and players.
- identify commercial opportunities by analyzing trends and co-development.
- excel data sheet with numerous data points of the actigraphy sensors and PSG devices market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global actigraphy sensors and PSG devices market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by Configuration
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of sleep disorders
4.1.1.2. Rise of advancements in the devices
4.1.2. Restraints
4.1.2.1. Challenges associated with the devices
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Actigraphy Sensors *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polysomnography Devices
8. By Application
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Sleep Monitoring *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Fitness Monitoring
8.4. Disease Monitoring
8.5. Clinical Research
8.6. Others
9. By Configuration
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
9.1.2. Market Attractiveness Index, By Configuration
9.2. Wristband *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neck and head bands
9.4. Sensor Caps
9.5. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics*
10.2.1. Introduction
10.2.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Homecare
10.4. Ambulatory Surgical Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. South Korea
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Koninklijke Philips N.V. *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Neurocare Group
13.3. Cadwell Laboratories Inc.
13.4. SOMNOmedics GmbH
13.5. ActiGraph LLC
13.6. Advanced Brain Monitoring Inc.
13.7. Nox Medical
13.8. BMC
13.9. Cidelec
13.10. Compumedics
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us